Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Neurologic Manifestations of the Arbovirus Infection in Colombia

NCT03206541

Conditions: Alphavirus Infections, Arbovirus Infections, Autoimmune Diseases, +40 more
Locations: Clinica Leon XIII Medellín, Antioquia, Colombia

Neuroclinica Medellín, Antioquia, Colombia

Clinica La Misericordia Internacional Barranquilla, Atlántico, Colombia

Hospital Universitario de Narino Pasto, Departamento de Nariño, Colombia

View Trial Details

Completed

Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR

NCT02669966

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +22 more
Locations: Shands at the University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Safety Study of Dengushield in Healthy Adults

NCT03883620

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
Locations: CMAX Clinical Research Pty Ltd Adelaide, South Australia, Australia

View Trial Details

Completed

'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'

NCT03088917

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Radboudumc Nijmegen, Gelderland, Netherlands

View Trial Details

Completed

Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma

NCT03109457

Conditions: Blood-Borne Infections, Carcinoma, Carcinoma, Squamous Cell, +16 more
Locations: Kasr ALini Hospital Giza, Cairo Governorate, Egypt

View Trial Details

Completed

Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge

NCT03416036

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States

Vaccine Testing Center, University of Vermont Burlington, Vermont, United States

View Trial Details

Completed

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

NCT01647191

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +12 more
Locations: Shanghai Hong Kou MMT clinic Shanghai, Shanghai Municipality, China

Shanghai Yang Pu MMT clinic Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

NCT03222583

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +27 more
Locations: Peking University Peoples Hospit /ID# 156846 Beijing, Beijing Municipality, China

Guangzhou Eighth People's Hosp /ID# 156859 Guangzhou, Guangdong, China

Guangdong General Hospital /ID# 156822 Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University /ID# 156860 Guangzhou, Guangdong, China

View all 48 locations

View Trial Details

Completed

T Regulatory Cells in Hepatitis c Infected Patients

NCT03186235

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Assiut University Asyut, Egypt

View Trial Details

Completed

Long-term Follow-up of HALT-C Sustained Virological Responders

NCT00825877

Conditions: Adenocarcinoma, Ascites, Blood-Borne Infections, +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions